Fig. 4.
Mean (SD) changes from baseline (day −1) in fasting plasma glucose (FPG) after treatment with multiple doses of empagliflozin or placebo (day 9). Data from the treated set (n = 48)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.